Back
Perion Network Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
30
PERI
Perion Network
Last Price:
8.96
Seasonality Move:
18.78%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
38.01
Seasonality Move:
3.65%
Sell
30
Perion Network (PERI)
is a Sell
Is Perion Network a Buy, Sell or Hold?
- The current Perion Network [PERI] share price is $9.04. The Score for PERI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- PERI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PERI Stock Price Chart
What is Perion Network's stock price today?
-
The Perion Network share price today is $9.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PERI is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
PERI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.08 | Sell |
Relative Strength Index (14 RSI): | 31.03 | Sell |
Chaikin Money Flow: | -1288690 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.67 - 12.73) | Sell |
Bollinger Bands (100): | (11.21 - 24.05) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -836354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.26 - 42.36) | Sell |
Bollinger Bands (100): | (41.26 - 48.86) | Sell |
PERI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.24 | Sell |
20-day SMA: | 10.96 | Sell |
50-day SMA: | 11.69 | Sell |
200-day SMA: | 23.41 | Sell |
8-day EMA: | 9.48 | Sell |
20-day EMA: | 10.57 | Sell |
50-day EMA: | 12.86 | Sell |
200-day EMA: | 21.19 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.11 | Sell |
20-day SMA: | 40.61 | Sell |
50-day SMA: | 42.43 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 40.32 | Sell |
20-day EMA: | 40.92 | Sell |
50-day EMA: | 42.29 | Sell |
200-day EMA: | 43.55 | Sell |
Perion Network Earnings Growth & PERI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.05 per share, a decrease this year of $1.96 per share, and a decrease next year of $0.24 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Perion Network Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |